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MATERIAL AND METHODS 
 
Population 
The European Community Respiratory Health Survey (ECRHS) is a multicentre study in the general 
population (http://www.ecrhs.org/) conducted among adults from 56 centres in 25 countries with a baseline 
survey as the first step. The aims were to evaluate variation in prevalence of asthma, asthma-like symptoms, 
atopic sensitization and bronchial reactivity among countries and how identified risk factors and treatment 
explain this variation. The baseline ECRHS study (ECRHS I) was conducted, from 1991 to 1993 among 
participants from 45 centres in 22 countries, as previously described 1, 2. A random sample among at least 
1500 men and 1500 women in each area, aged 20 to 44 years, was contacted to complete a short screening 
questionnaire on respiratory symptoms. Second, both a 20% random sample (participants from the screening 
questionnaire) and a respiratory symptom-enriched sub-group (those who reported asthma attacks, asthma 
medication, or ’wake up by shortness of breath’ in the screening questionnaire but not selected in the random 
sample) were invited to participate in a clinical examination. Participants were asked to complete a second 
detailed questionnaire that included information on smoking habits, occupation, home environment, 
respiratory symptoms, asthma and treatment. In addition, lung function tests including methacholine 
challenge for non- specific bronchial reactivity were performed. 
All participants from ECRHS I were invited to participate again in a follow-up survey (ECRHS II) 
conducted between 1998 to 2002, as previously described3. Participants were invited to complete a face-to-
face administrated questionnaire (including detailed information on asthma, respiratory symptoms, and 
occupational history) and to participate in a clinical examination (lung function tests, blood samples). The 
information collected also included age, smoking status (never, former or current smoker), body mass index 
(BMI: ≥25 kg/m², Yes/no), age at full time education (< 17, 17-20, > 20 years old), an asthma symptom 
score, use of inhaled corticosteroids and sensitization. Participants classified ‘with sensitization to common 
allergens’ have specific serum Immunoglobuline E antibodies to at least one out of four common inhalant 
allergen (house dust mite, grass, cat and Cladosporium herbarum) at concentrations of 0·35 U/mL or more. 
Bronchial hyper-reactivity (BHR) was defined as a reduction in maximum FEV1 of at least 20% of its 
postsaline value for a methacholine dose of 1 mg or less. According to baseline FEV1 based on Quanjer et 
al. reference values, participants were classified as ‘with’ (< 80% of predicted values) or ‘without’ low 
FEV1. 
The response rate for the follow-up participation was approximately 65% overall. This analysis was 
limited to participants in ECRHSII from the 26 study centres in 12 countries3, 4. The information was used to 
evaluate both asthma control and occupational exposure among participants ever employed and with 
available data for sex, age, smoking habits, current asthma (n=9019). Among participants from the enriched 
sample, more prone to respiratory symptoms or diseases, only those with current asthma were included in the 
present analysis, as previously 5. After excluding of 1942 participants, 796 participants from the enriched 
sample (all individuals without current asthma) and 1146 from the random sample (with past asthma (n=167)  
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or without current asthma but with asthma symptoms or treatment in ECRHSII (n=979)), analysis was 
performed on 7077 participants (1210 with ‘current asthma’; 5867 with ‘never asthma’, Figure 1).  
Four geographical areas were defined as previously5: English speaking (UK and USA), Northern 
(Estonia, Iceland, Norway, and Sweden), Central (Belgium, France, Germany, and Switzerland) and 
Southern (Italy and Spain) Europe areas.  
As previously described by Sunyer et al and Pekkanen et al6, 7, an asthma symptom score was calculated 
by the sum of positive answers to 5 items from a standardized questionnaire: 1) breathless while wheezing in 
the last 12 months, 2) woken up with a feeling of chest tightness in the last 12 months, 3) attack of shortness 
of breath at rest in the last 12 months, 4) attack of shortness of breath after exercise in the last 12 months, 5) 
woken by attack of shortness of breath in the last 12 months. A 3-level classification (0, 1, at least 2 
symptoms) was considered. 
Ethical approval to perform the study was obtained from the relevant ethic committee from each centre, 
and written informed consent was received from all participants. 
 
Asthma phenotypes 
Participants from the random sample were classified with ‘never asthma’ (n=5867) if they never 
reported doctor-diagnosed asthma (never at ECRHSI and ECRHSII), and nor asthma-like symptoms 
(wheezing or whistling without a cold, woken by an attack of shortness of breath) nor use of asthma 
medications at ECRHS II.  
Participants were classified with ‘current asthma’ at follow-up (n=1210), as previously described by de 
Marco et al 8 and Cazzoletti et al 4, 9, if they had reported doctor-diagnosed asthma and if, in the last 12 
months, they had reported respiratory symptoms (wheezing, nocturnal chest tightness, attack of 
breathlessness following activity, at rest or at night time, at least 1 asthma attack) or had used asthma 
medications.  
Participants without current asthma at ECRHSII and who reported a history of ever asthma at ECRHSI or 
ECRHSII (asthma in remission, n=167) or asthma-like symptoms or asthma medication at ECRHSII (n=979) 
were excluded from the present analyses (Figure 1), as previously performed3. 
Among participants with current asthma, asthma control was defined, as previously described by 
Cazzoletti et al4, combining diurnal and nocturnal respiratory symptoms, asthma attacks, activity limitations, 
lung function, hospitalization for asthma and use of treatment for asthma. Participants with ‘current asthma’ 
were classified as: (i) ‘Controlled asthma’ if all the following features were present: diurnal symptoms less 
than once a week (see online supplement, question Q14.9), no nocturnal symptoms (Q14.8), no asthma 
attacks (Q14.7), short-acting β2-agonists twice or less per week in the past 3 months; no activity (work, other  
Online supplement  10/06/2013 
N Le Moual et al – ECRHSII - Occupational exposures and uncontolled adult-onset asthma    4 
 
 
activities) limitations (Q90.1, Q91) and no use of oral steroids in the past 12 months, and FEV1 ≥ 80% 
predicted. (ii) ‘Partly-controlled asthma’ when 1 or 2 of the above features were absent. (iii) ‘Uncontrolled 
asthma’ when asthma, shortness of breath or wheezing had caused hospital/emergency admissions in the 
past 12 months (Q84.1, Q85.1); or oral corticosteroids were used on short courses or continuously in the past 
12 months (Q77.3.3); or the participant had more than 12 asthma attacks (>1/week) in the past 3 months; or 
> 3 of the above features were absent.  
It has been suggested that exacerbations should be considered separately from ‘current clinical control’ 
because they may occur even if the patient has adequate current control of symptoms and few activity 
limitations10. Therefore, further analysis was conducted without including the exacerbation domain in the 
asthma control definition (‘current clinical control’ domain). ‘Current clinical control’ domain was defined 
as previously for ‘Controlled asthma’ and ‘Partly-controlled asthma’ whereas participants with ‘current 
asthma’ were classified as ‘Uncontrolled asthma’ when the participant had more than 12 asthma attacks 
(>1/week) in the past 3 months; or > 3 of the above features were absent (exacerbations not taken into 
account to defined uncontrolled asthma).  
Age at asthma onset (childhood, adult), reported to be a key factor in asthma phenotype 11, should be 
considered, especially in work-related asthma studies. Information collected at follow-up and at baseline was 
used to evaluate the age at asthma onset. Participants with asthma, and without inconsistent responses 
regarding age at asthma onset, were classified as ‘adult-onset asthma’ when the age at asthma onset was 
greater than 16 years old and as ‘childhood-onset asthma’ when age of atshma was lower than 16, as 
previously defined 12, 13. Studying the "healthy worker hire effect" in ECRHS14, completion of fulltime 
education and age of 16-years old have been used to define childhood and adulthood -onset asthma. 
Whatever the cut-off used for asthma onset (age of 16 years; completion of fulltime education) the results 
were similar. Among participants with current asthma, 91 were excluded from some analyses due to missing 
values or inconsistent responses at the two surveys for the age at asthma onset.  
 
Occupational exposure 
All occupations held for at least three months during the follow-up between the ECRHS I and II 
(evaluated retrospectively at ECRHS II) were recorded in a face-to-face interview. Jobs were coded using the 
International Standard Classification of Occupations (ISCO-88) system15. Both past 12-month and 10-year 
(between ECRHS I and II; evaluated retrospectively at ECRHS II) occupational exposures were evaluated 
through an asthma job-exposure matrix (Asthma-specific JEM) 16 designed to give correspondence between 
jobs and exposures after translation of job descriptions into International Standard Classification of 
Occupations (ISCO88) codes 15. The asthma-specific JEM is a two-dimensional table with the first axis 
listing international job codes. The second axis contains 22 exposure estimates coded as yes or no in the 
cells. Among the 22 exposure estimates, 18 categories of asthmagens were classified at high risk for asthma  
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and four categories of products a priori ‘non-asthmagenic’ agents were classified at low risk for asthma) at 
the set-up of the Asthma JEM. As explained previously 16, 17 and updated on the Asthma-specific JEM’s 
website (http://cesp.vjf.inserm.fr/asthmajem/), individuals were classified exposed to a priori ‘non-
asthmagenic agents’ or ‘at low risk for asthma’ when they may be exposed to (a) 3 categories of respiratory 
hazards not likely associated with occupational asthma (vehicle or motor exhaust fumes; high probability of 
exposure to environmental tobacco smoke; possible exposure to irritant gasses or fumes) or (b) to 
‘asthmagens’ but with low probability of enough exposure to induce occupational asthma. We agree that this 
classification of a priori ‘non-asthmagenic’ agents may be discussed according to current knowledge, 
especially for low to moderate exposures to irritants. The JEM was first applied to job codes, followed by a 
second step where expert re-evaluation was undertaken, as previously described in the ECRHSII survey 3. 
Participants were classified as ‘exposed to asthmagens’ (HMW, LMW, mixed environment (which could 
involve combined exposures to irritants, HMW and LMW agents), or high peak irritants), exposed to a priori 
‘non-asthmagenic’ agents only (participants exposed to both ‘asthmagens’ and ‘non-asthmagenic’ agents 
were classified only exposed to’ asthmagens’ for the present analysis) or ‘non exposed’. Occupational 
exposure to cleaning agents (LMW agents) was also assessed by this method. 
 
Statistical analysis 
Analyses were stratified by BMI, smoking habits, gender, and sensitization as previously suggested3, 18.  
A meta-analysis by geographical areas was also performed. Further analysis was conducted without 
including the exacerbation domain in the asthma control definition (‘current clinical control’ domain; see 
methods and Table 3).  
Population attributable risks (PAR) were calculated for occupational contribution to uncontrolled asthma, 
considering past 12-month and 10-year exposure to asthmagens (proportion exposed): “proportion exposed × 
(odds ratio – 1)” divided by “(proportion exposed × (odds ratio – 1)) + 1”, as previously described19, 20. 
 
 
 
ADDITIONAL RESULTS 
 
Additional analyses were performed among participants with adult-onset asthma. Similar but non 
significant associations were observed between 12-month occupational exposure to asthmagens in general 
(1.5[0.8-2.7]), HMW (1.6[0.8-3.5]), LMW (1.4[0.7-2.7]), cleaning agents (1.6[0.7-3.8]) and uncontrolled 
asthma compared to participants with controlled asthma. The ORs for 10-year occupational exposure were 
similar or slightly lower. ORs lower than one were observed for partly-controlled asthma. According to 
asthma control dimensions, similar associations were observed for exacerbations, with lower associations for 
10-year than for 12-month occupational exposure. For lung function, no significant associations were  
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observed. However an OR greater than 2 was observed between 12-month exposure to LMW agents and 
FEV < 80% compared to participants with controlled asthma. Increased risks were observed for 10-year 
occupational exposures to all asthmagens (1.5 to 2.7). No association was observed for the symptoms and 
activity limitations domains. Association between 10-year occupational exposure and uncontrolled asthma 
was stratified on BMI, smoking status, sensitization and gender. No significant associations were observed 
between exposure and uncontrolled asthma (vs controlled) except for HMW agents (2.5[1.0-6.2) among 
smokers. Higher ORs (from 1.4 to 2.0) were observed among non-smokers with OR lower than one for 
smokers. Higher ORs were observed among non-overweight participants with a stronger association for 
HMW agents. Higher ORs was observed in non-atopic participants. ORs were higher in men than in women 
for exposure to asthmagens in general whereas higher ORs were observed in women for LMW agents 
including cleaning agents. 
 
Population attributable risks for uncontrolled adult-onset asthma were calculated for 12-month and 10-
year occupational exposure to asthmagens and were found to be 9.4% and 12.6%, respectively.  
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Table E1 - Description of the ECRHS II population according to asthma status 
 All participants  Current asthma  
 All 
 
n=7,077 
Never 
asthma 
n=5,867 
Current  
asthma 
n=1,210 
p 
value 
Childhood 
onset  
n=503 
Adult 
onset  
n=616 
p 
value 
Women,%   51.8 50.6 57.7 ** 46.3 66.7 ** 
Age, mean (SD)  42.8 (7.2) 42.9 (7.1) 42.1 (7.2) 0.001 40.2 (7.0) 43.9 (6.8) ** 
Body mass index,  %    
< 25 kg/m2 
25-30 kg/m2 
> 30 kg/m2 
 
n=6,071 
52.5 
35.2 
12.3 
n=5,033 
53.6 
35.1 
11.3 
n=1,038 
47.0 
35.6 
17.4 
** n=419 
51.1 
34.8 
14.1 
n=539 
44.3 
36.4 
19.3 
0.05 
Smoking habits, %    
Non smokers 
Ex-smokers 
Current smokers 
 
 
45.2 
27.9 
26.9 
 
44.6 
28.3 
27.1 
 
48.1 
26.0 
25.9 
0.08  
52.3 
26.4 
21.3 
 
45.8 
26.5 
27.7 
0.03 
Age finishing full-time 
education , %    
< 17 years old 
17 – 20 
> 20 
 
 
18.1 
35.1 
46.8 
 
17.0 
36.2 
46.8 
 
23.1 
30.1 
46.8 
**  
20.7 
28.2 
51.1 
 
24.8 
30.7 
44.5 
0.07 
Asthma job exposure matrix*, 
%  
       
Men 
Low risk for asthma 
High risk, Asthmagens 
 
27.2 
13.4 
 
27.4 
13.5 
 
26.3 
12.7 
ns  
26.4 
11.2 
 
27.2 
15.4 
ns 
Women 
Low risk for asthma 
High risk, Asthmagens 
 
 
6.7 
21.1 
 
6.2 
20.8 
 
8.9 
22.6 
0.03  
9.4 
19.3 
 
 
8.1 
24.6 
 
ns 
Used of inhaled 
corticosteroids, past 12 
months %  
 
7.1 0.0 42.3 - 39.6 
 
44.7 0.09 
Sensitization n=5,731 
30.0 
n=4,736 
23.2 
n=995 
62.3 
** n=401 
76.8 
n=516 
50.6 
** 
FEV1% predicted, mean (SD)    n=6,046 
99.4 (14.1) 
n=5012 
101.2 (12.9) 
n=1034 
90.9 (16.1) 
** n=418 
90.7 (16.4) 
n=536 
91.0 (16.1) 
ns 
BHR, %  n=4,571 
14.4 
n=3,905 
8.0 
n=666 
52.1 
** n=270 
59.6 
n=343 
47.8 
0.004 
        
** p< 0.001 
* Past 12-month occupational exposures were evaluated through an asthma-specific job-exposure matrix (Kennedy et 
al, OEM 2000) which allowed estimation of exposure to 4 a priori ‘non-asthmagenic agents’ at low risk for asthma 
(low probability of exposure to asthmagens, exhaust fumes, high probability of exposure to environmental tobacco 
smoke, possible exposure to irritants) and exposure to 18 asthmagens  at high risk for asthma (classified in 4 large 
categories: high molecular, low molecular weight agents, mixed environments, irritants peaks) including cleaning 
agents. For the present analysis, participants were classified as exposed to a priori ‘non-asthmagenic’ agents 
(considered at low risk for asthma when the asthma JEM was set up) only if they are not considered in addition as 
exposed to ‘asthmagens’ (see online supplement). 
Sensitization was defined as a specific serum Immunoglobuline E antibodies to at least one out of four common 
inhalant allergen (house dust mite, cat, timothy grass or Cladosporium herbarum) at concentrations of 0.35 U/mL or 
more. According to baseline forced expiratory volume in the first second (FEV1) based on Quanjer et al. reference 
values17, participants were classified as ‘with’ (< 80% of predicted values) or ‘without’ low FEV1. Bronchial hyper-
reactivity (BHR) was defined as a reduction in maximum FEV1 of at least 20% of its postsaline value for a 
methacholine dose of 1 mg or less. 
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Table E2-Description of ECRHS II population with asthma according to asthma control CHILDHOOD ONSET* 
 Controlled  
asthma 
n=132 
Partly 
controlled 
n=135 
Uncontrolled 
asthma 
n=143 
p value 
Women,%  43.2 44.4 51.8 ns 
Age, mean (SD)  40.3 (6.7) 40.5 (7.1) 40.3 (7.2) ns 
Sensitization to common allergens n=119 
74.0 
n=118 
78.0 
n=113 
80.5 
ns 
Total IgE > 100 kU/L, % n=120 
47.5 
n=118 
55.9 
n=114 
62.3 
0.07 
BHR, %  
 
n=99 
48.5 
n=84 
66.7 
 
n=57 
82.5 
< 0.001 
Used of inhaled corticosteroids, last 12 months %  
 
n=131 
16.8 
n=131 
40.5 
 
n=142 
68.3 
< 0.001 
Oral corticosteroids, past 12 months# 0.0 3.7 20.4 < 0.001 
Asthma symptom score, %  
0 
1 
2 
3 
4 
5 
 
n=131 
22.1 
38.2 
23.7 
9.2 
3.8 
3.0 
n=130 
11.5 
20.0 
30.0 
19.3 
11.5 
7.7 
n=143 
0.7 
4.9 
18.2 
18.9 
30.8 
26.5 
< 0.001 
Four domains of asthma control, % n=132 
 
n=135 
 
n=143 
 
 
Lung function (Quanjer), FEV1 < 80% 0.0 14.3 37.8 < 0.001 
Symptoms, past 3 months 0.0 51.1 91.6 < 0.001 
Exacerbations, past 12 months 0.0 0.0 30.1 < 0.001 
Activity limitation, past 12 months 0.0 24.4 44.1 < 0.001 
Smoking habits, % 
Non smokers 
Ex-smokers 
Current smokers 
 
n=132 
49.2 
27.3 
23.5 
n=135 
53.3 
28.2 
18.5 
n=143 
52.5 
27.3 
20.3 
ns 
Age finishing full-time education , %    
< 17 years old 
17 – 20 
> 20 
 
n=132 
19.0 
28.0 
53.0 
n=135 
21.5 
27.4 
51.1 
n=143 
19.6 
33.6 
46.8 
ns 
Body mass index, mean (SD),% 
< 25 kg/m2 
25-30 kg/m2 
> 30 kg/m2 
 
n=130 
56.9 
36.2 
6.9 
n=124 
54.8 
30.7 
14.5 
n=121 
47.1 
35.5 
17.4 
0.10 
“Have you had to leave jobs (during follow-up) because 
it affected your breathing?” 
 
n=131 
6.1 
n=132 
6.1 
n=137 
8.8 
 
ns 
Asthma-specific job exposure matrix, % n=132 n=135 n=143 ns 
Non-asthmagenic irritants, in life 21.2 21.5 18.2  
Asthmagens, in life 17.4 17.8 17.5  
* Out of 503 participants with childhood-onset asthma, 410 were classified as controlled, partly or uncontrolled 
asthma (n=93 missing values for asthma control) 
# use of oral corticosteroids ‘when needed’, ‘continuously’, ‘in short courses’(see Question 3, annex 1)  
Sensitization to common allergens was defined as a specific serum Immunoglobuline E antibodies to at least one out of 
four common inhalant allergen (house dust mite, cat, timothy grass or Cladosporium herbarum) at concentrations of 
0.35 U/mL or more. 
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 According to baseline forced expiratory volume in the first second (FEV1) based on Quanjer et al. reference values
17, 
participants were classified as ‘with’ (< 80% of predicted values) or ‘without’ low FEV1. 
Bronchial hyper-reactivity (BHR) was defined as a reduction in maximum FEV1 of at least 20% of its postsaline value 
for a methacholine dose of 1 mg or less. 
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Table E3– Relationship between 12-month and 10-year occupational exposure to asthmagens and asthma in ECRHS II 
 
 12-month occupational exposure, Asthma JEM* 10-year occupational exposure, Asthma JEM* 
 All 
A/HMW/LMW/C 
Exposed, n 
Asthmagen, 
all 
 
HMW, any 
 
LMW, any 
 
Cleaning 
agents 
 
All 
A/HMW/LMW/C 
Exposed, n 
Asthmage
n all 
 
HMW, 
any 
 
LMW, 
any 
 
Cleaning 
agents 
 
Never asthma  
(reference) 
4424 
910/ 471/ 567/ 243 
1.0 1.0 1.0 1.0 4771 
1172/ 607/ 748/ 345 
1.0 1.0 1.0 1.0 
Current 
asthma 
 
879 
191/ 111/116/65 
1.0 
[0.8-1.2] 
1.0 
[0.8-1.3] 
0.9 
[0.7-1.2] 
1.1 
[0.8-1.4] 
999 
270/ 161/177/112 
1.0 
[0.9-1.2] 
1.1 
[0.9-1.3] 
1.0 
[0.8-1.2] 
1.2 
[0.9-1.5] 
Age at asthma onset#          
Childhood-
onset 
364 
66/ 35/41/17 
0.8 
[0.6-1.1] 
0.8 
[0.6-1.2] 
0.8 
[0.6-1.1] 
0.8 
[0.5-1.4] 
400 
90/ 50/58/26 
0.8 
[0.6-1.0] 
0.8 
[0.6-1.1] 
0.8 
[0.6-1.0] 
0.7 
[0.5-1.1] 
Adult-onset 
 
449 
112/ 67/ 66/ 42 
1.2 
[0.9-1.5] 
1.2 
[0.9-1.6] 
1.0 
[0.8-1.4] 
1.3 
[0.9-1.8] 
522 
163/ 100/ 107/ 78 
1.3 
[1.1-1.6] 
1.3 
[1.0-1.7] 
1.3 
[1.0-1.6] 
1.6 
[1.2-2.2] 
Adjusted for age, sex, smoking habits, country (random effect) 
 Reference: participants with ‘never asthma’ 
* Participants exposed to asthmagens were compared to non exposed participants (participants exposed to non-asthmagens excluded).  A: asthmagens; 
HMW: high molecular weight agents; LMW: low molecular weight agents; C: Cleaning agents 
# To study associations between occupational exposures and current asthma according to age at asthma onset, nominal logistic regressions were performed 
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Figure E1 – Relationship between 10-year occupational exposure to asthmagens and uncontrolled adult-
onset asthma (vs. never asthma) stratified by BMI, Smoking, Sensitization, Gender 
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Adjusted for age, sex, smoking habits, country (random effect); Reference: participants with ‘never asthma’  
Participants exposed to non-asthmagenic agents or exposed to asthmagens were compared to non-exposed participants 
BMI: body mass index 
Atopic sensitization: participants classified ‘with sensitization’ have specific serum Immunoglobuline E antibodies to at least 
one out of four common inhalant allergen (house dust mite, cat, timothy grass or Cladosporium herbarum) at concentrations of 
0·35 U/mL or more. 
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Annex 1 - Questions used to evaluate the three domains of asthma control 
 
1- Lung function (FEV1 ≥ 80% predicted, yes/no), at the exam 
 
2- Symptoms, in past 3 months 
 
Q14.5 Have you had an attack of asthma in the last 12 months?  
Q14.6 How many attacks of asthma have you had in the last 12 months?  
Q14.7 How many attacks of asthma have you had in the last 3 months?  
 
 
Q14.8 How many times have you woken up because of your asthma in the last 3 months?  
 
every night or almost every night  1  
more than once a week, but not most nights  2  
at least twice a month, but not more than once a week  3  
less than twice a month  4  
not at all  5  
 
Q14.9 How often have you had trouble with your breathing because of your asthma in the last 3 months?  
 
continuously  1  
about once a day  2  
at least once a week, but less than once a day  3  
less than once a week  4  
not at all  6  
 
 
3- Exacerbations, in past 12 months 
 
Q77.3 oral steroids  
Q77.3.3 In the last 12 months, how have you used them:  
a) when needed  
 
1  
b) in short courses  2  
c) continuously  3  
 
Q84. Since the last survey have you visited a hospital casualty department or emergency room because of 
breathing problems?  
 Q84.1 Have you visited a hospital casualty department or emergency room because of breathing 
problems in the last 12 months?  
 
Q85. Since the last survey have you spent a night in hospital because of breathing problems?  
 Q85.1 Have you spent a night in hospital because of breathing problems in the last 12 months?  
 
 
4- Limitation of activity, in past 12 months 
 
Q90. Are you currently working?  
Q90.1. How many days of work have you lost because of asthma, shortness of breath or wheezing in the last 
12 months?  
 
Q91. Have there been any days when you have had to give up activities other than work e.g. looking after 
children, the house, studying) because of your asthma, wheezing or shortness of breath in the last 12 months? 
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